Biology Reference
In-Depth Information
64. Liu L, NakatsuruY, Gerson SL. Base excision repair as a thera-
peutic target in colon cancer.
Clin Cancer Res
2002;
81. Esteller M, Gaidano G, Goodman SN, et al. Hypermethylation of
the DNA repair gene O(6)-methylguanine DNA methyltransfer-
ase and survival of patients with diffuse large B-cell lymphoma.
J Natl Cancer Inst
2002;
99.
65. Liu L, Yan L, Donze JR, Gerson SL. Blockage of abasic site repair
enhances antitumor efficacy of BCNU in colon tumor xenografts.
Mol Cancer Ther
2003;
8
:2985
e
32.
82. Pulling LC, Divine KK, Klinge DM, et al. Promoter hyper-
methylation of the O6-methylguanine-DNA methyltransferase
gene: more common in lung adenocarcinomas from never-
smokers than smokers and associated with tumor progression.
Cancer Res
2003;
(1):26
94
e
78.
66. Yan L, Bulgar A, Miao Y, Mahajan V, Donze J, Gerson SL, Liu L.
Combined treatment of temozolomide with methoxyamin: inhi-
bition of AP site repair coupled with the action of a top-
oisomerase II
:1061
2
e
9.
67. von Wronski MA, Harris LC, Tano K, Mitra S, Bigner DD,
Brent TP. Cytosine methylation and suppression of O6-methyl-
guanine-DNA methyltransferase expression in human rhabdo-
myosarcoma cell lines and xenografts.
Oncol Res
1992;
a
poison.
Clin Cancer Res
2007;
:1532
13
e
8.
83. Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H.
Promoter methylation of the DNA repair gene MGMT in
astrocytomas is frequently associated with G: C -> A: T muta-
tions of the TP53 tumor suppressor gene.
Carcinogenesis
2001;
22
63
(16):4842
e
74.
68. Harris LC, Remack JS, Brent TP. In vitro methylation of the
human O6-methylguanine-DNA methyltransferase promoter
reduces transcription.
Biochim Biophys Acta
1994;
4
:167
e
9.
84. Zhang L, Lu W, Miao X, Xing D, Tan W, Lin D. Inactivation of
DNA repair gene O6-methylguanine-DNA methyltransferase by
promoter hypermethylation and its relation to p53 mutations in
esophageal squamous cell carcinoma.
Carcinogenesis
2003;
(10):1715
e
6.
69. von Wronski MA, Brent TP. Effect of 5-azacytidine on expression
of the human DNA repair enzyme O6-methylguanine-DNA
methyltransferase.
Carcinogenesis
1994;
(2):141
1217
e
24
(6):
82.
70. Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO.
Graded methylation in the promoter and body of the O6-meth-
ylguanine DNA methyltransferase (MGMT) gene correlates with
MGMT expression in human glioma cells.
(4):577
15
e
44. Epub 2003 Apr 24.
85. Zuo C, Ai L, Ratliff P, et al. O6-methylguanine-DNA methyl-
transferase gene: epigenetic silencing and prognostic value in
head and neck squamous cell carcinoma.
Cancer Epidemiol
Biomarkers Prev
2004;
1039
e
J Biol Chem
75.
86. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation
and field defect in sporadic colorectal cancer.
J Natl Cancer Inst
2005;
(6):967
13
e
37.
71. Harris LC, von Wronski MA, Venable CC, Remack JS, Howell SR,
Brent TP. Changes in O6-methylguanine-DNA methyltransferase
expression during immortalization of cloned human fibroblasts.
Carcinogenesis
1996;
1994;
:17228
269
e
(18):13
30
8.
87. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and
benefit
97
e
24.
72. Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS,
Futscher BW. Methylation of discrete regions of the O6-methyl-
guanine DNA methyltransferase (MGMT) CpG island is associ-
ated with heterochromatinization of the MGMT transcription
start site and silencing of the gene.
Mol Cell Biol
1997;
:219
2
e
from temozolomide in glioblastoma.
N Engl
J Med
1003.
88. Paz MF, Yaya-Tur R, Rojas-Marcos I, et al. CpG island hyper-
methylation of the DNA repair enzyme methyltransferase
predicts response to temozolomide in primary gliomas.
Clin
Cancer Res
2004;
2005;
352
(10):997
e
9.
73. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG.
Inactivation of the DNA repair gene O6-methylguanine-DNA
methyltransferase by promoter hypermethylation is a common
event in primary human neoplasia.
Cancer Res
1999;
:5612
8.
89. Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK.
MGMT promoter methylation correlates with survival benefit
and sensitivity to temozolomide in pediatric glioblastoma.
Pediatr
Blood Cancer
2007;
(15):4933
17
e
10
e
7.
74. Christmann M, Pick M, Lage H, Schadendorf D, Kaina B.
Acquired resistance of melanoma cells to the antineoplastic agent
fotemustine is caused by reactivation of the DNA repair gene
MGMT.
Int J Cancer
2001;
59
(4):793
e
7.
90. Weller M, Felsberg J, Hartmann C, et al. Molecular predictors of
progression-free and overall survival in patients with newly
diagnosed glioblastoma: a prospective translational study of the
German Glioma Network.
J Clin Oncol
2009;
48
(4):403
e
9.
75. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methyl-
ation of O-6-methylguanine DNA methyltransferase character-
izes a subset of colorectal cancer with low-level DNA
microsatellite instability.
Cancer Res
2001;
(1):123
50.
91. Blanc JL, Wager M, Guilhot J, et al. Correlation of clinical features
and methylation status of MGMT gene promoter in glioblas-
tomas.
J Neurooncol
2004;
(34):5743
92
e
27
e
83.
92. Hayakawa H, Koike G, Sekiguchi M. Expression and cloning of
complementary DNA for a human enzyme that repairs O6-
methylguanine in DNA.
J Mol Biol
1990;
(3):275
68
e
30.
76. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the
DNA-repair gene MGMT and the clinical response of gliomas to
alkylating agents.
N Engl J Med
2000;
(3):827
61
e
47.
93. Rydberg B, Spurr N, Karran P. cDNA cloning and chromosomal
assignment of the human O6-methylguanine-DNA methyl-
transferase. cDNA expression in
Escherichia coli
and gene
expression in human cells.
J Biol Chem
1990;
213
(4):739
e
4.
77. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of
the DNA repair gene O6-methylguanine-DNA methyltransferase
by promoter hypermethylation is associated with G to A muta-
tions
343
(19):1350
e
9.
94. Tano K, Shiota S, Collier J, et al. Isolation and structural charac-
terization of a cDNA clone encoding the human DNA repair
protein for O6-alkylguanine.
Proc Natl Acad
(16):9563
265
e
in
K-ras
in colorectal
tumorigenesis.
Cancer Res
71.
78. Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS. Impaired
expression and promotor hypermethylation of O6-methyl-
guanine-DNA methyltransferase in retinoblastoma tissues.
Invest
Ophthalmol Vis Sci
2002;
2000;
(9):2368
60
e
Sci, USA
90.
95. Hazra TK, Roy R, Biswas T, et al. Specific recognition of O6-
methylguanine in DNA by active site mutants of human O6-
methylguanine-DNA methyltransferase.
Biochemistry
1997;
1990;
87
(2):686
e
9.
79. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W.
Promoter methylation status of the DNA repair genes hMLH1
and MGMT in gastric carcinoma and metaplastic mucosa.
Pathobiology
2001;
43
(5):1344
e
(19):
36
76.
96. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious
adverse event after successful gene therapy for X-linked severe
combined immunodeficiency.
N Engl J Med
2003;
5769
e
9.
80. Hayashi H, Yazawa T, Okudela K, et al. Inactivation of O6-
methylguanine-DNA methyltransferase in human lung adeno-
carcinoma relates to high-grade histology and worse prognosis
among smokers.
Jpn J Cancer Res
2002;
(3):143
69
e
6.
97. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-
associated clonal T cell proliferation in two patients after gene
therapy for SCID-X1.
Science
2003;
(3):255
348
e
93
(2):184
e
9.
302
(5644):415
e
9.
